Archive · 31 Jul 2025
Three-Parent Babies: Breakthrough in Reproduction
Imagine your body's cells have tiny power plants called mitochondria.
Sometimes, these power plants don't work right, leading to diseases passed from mothers to babies.
A new technique called MRT helps fix this.
Doctors take the mother's egg, remove the bad power plants, and replace them with healthy ones from a donor.
This egg is then fertilized, creating a baby with genetic material from three people.
So far, babies born this way seem healthy, but scientists are still watching to make sure there aren't any problems later on.
Mitochondrial replacement therapy (MRT) allows for the creation of babies with genetic material from three people.
The primary goal of MRT is to prevent the transmission of mitochondrial diseases from mother to child.
MRT involves replacing a mother's faulty mitochondria with healthy ones from a donor egg.
Eight babies were born via MRT in 2015, and follow-up studies show they are healthy.
One concern is heteroplasmy, where some faulty mitochondrial DNA may still be present.
- Who
- Couples where the mother carries a mitochondrial disease.
- What
- Mitochondrial replacement therapy, a method using genetic material from three people to prevent mitochondrial diseases.
- When
- The technique was developed around 2014, with the first babies born in 2015, and trials starting in the UK in 2017.
- Where
- The technique was developed in the UK, with subsequent births and studies taking place in various locations.
- Why
- To prevent the inheritance of mitochondrial diseases that can cause serious health problems in children.
Potential Risks
Proven Benefits
Risk of faulty DNA
Potential Risks
Heteroplasmy: Some faulty mitochondrial DNA from the mother might still be present, potentially causing health issues later in life.
Proven Benefits
Most babies born via MRT have shown no immediate signs of mitochondrial defects.
- Technique Name
- Mitochondrial replacement therapy (MRT)
- Involved Parties
- Two women and one man
- Primary Purpose
- Preventing mitochondrial diseases
- First Babies Born
- 2015
- Follow-up Study Results
- Healthy and free from hereditary diseases
- Potential Risk
- Heteroplasmy (carryover of some faulty mitochondrial DNA)